PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China.\', \'Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, Sichuan, China.\', \'Wuhan Blood Center, Wuhan, Hubei, China.\', \'Anhui Medical University, Hefei, China.\', \'University of Miami, Miami, Florida, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/trf.15921
?:hasPublicationType
?:journal
  • Transfusion
is ?:pmid of
?:pmid
?:pmid
  • 32491199
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.645
?:rankingScore_hIndex
  • 120
is ?:relation_isRelatedTo_publication of
?:title
  • Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all